| Ticker Details |
Charles River Laboratories International, Inc.
Charles River Laboratories International Inc is a pharmaceutical company providing drug discovery and development services. The company provides animal models for laboratory testing, and offers manufacturing testing services to various industries.
|
| IPO Date: |
June 23, 2000 |
| Sector: |
Healthcare |
| Industry: |
Life Sciences Tools and Services |
| Market Cap: |
$7.72B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.55 | 1.22%
|
| Avg Daily Range (30 D): |
$3.75 | 2.18%
|
| Avg Daily Range (90 D): |
$4.09 | 2.32%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.53M |
| Avg Daily Volume (30 D): |
.62M |
| Avg Daily Volume (90 D): |
.72M |
| Trade Size |
| Avg Trade Size (Sh.): |
85 |
| Avg Trade Size (Sh.) (30 D): |
38 |
| Avg Trade Size (Sh.) (90 D): |
39 |
| Institutional Trades |
| Total Institutional Trades: |
13,659 |
| Avg Institutional Trade: |
$4.41M |
| Avg Institutional Trade (30 D): |
$13.5M |
| Avg Institutional Trade (90 D): |
$12.93M |
| Avg Institutional Trade Volume: |
.04M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$9.09M |
| Avg Closing Trade (30 D): |
$26.49M |
| Avg Closing Trade (90 D): |
$26.6M |
| Avg Closing Volume: |
58.18K |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$-3.7
|
$-.3
|
$-5.57
|
|
Diluted EPS
|
$-3.7
|
$-.3
|
$-5.56
|
|
Revenue
|
$4.03B
|
$995.83M
|
$994.23M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-182.84M
|
$-14.8M
|
$-276.29M
|
|
Operating Income / Loss
|
$70.39M
|
$119.9M
|
$-283.44M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$-33.53M
|
$-17.8M
|
$6.78M
|
|
PE Ratio
|
|
|
|
|
|
|
